drugset / Trial / NCT00051441

Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx

NCT00051441

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the effectiveness and safety of benzydamine hydrochloride 0.15% oral rinse to a vehicle oral rinse in the treatment of radiation-induced oral mucositis, and to compare the care normally used for radiation-induced oral mucositis to vehicle oral rinse to ensure that the vehicle does not have detrimental effects on the oral mucosa

Timeline

Start
Primary completion
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzydamine Unknown 0.15 % Oral